• Bruker Corp BRKR.OQ reported quarterly adjusted earnings of 60 cents​​ per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of 74 cents. The mean expectation of twelve analysts for the quarter was for earnings of 59 cents per share. Wall Street expected results to range from 52 cents to 64 cents per share.

• Revenue rose 16.4% to $864.40 million from a year ago; analysts expected $859.38 million.

• Bruker Corp's reported EPS for the quarter was 27 cents​.

• The company reported quarterly net income of $40.9 million.

• Bruker Corp shares had fallen by 11.2% this quarter and lost 16.5% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 6.2% in the last three months.​

• In the last 30 days, two analysts negatively revised earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," 3 "hold" and 2 "sell" or "strong sell."

• The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for Bruker Corp is $75.11

This summary was machine generated from LSEG data November 6 at 05:10 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)